224 related articles for article (PubMed ID: 35207500)
1. Immune Disregulation in Cutaneous Squamous Cell Carcinoma of Patients with Recessive Dystrophic Epidermolysis Bullosa: A Single Pilot Study.
Filoni A; Cicco G; Cazzato G; Bosco A; Lospalluti L; Tucci M; Cimmino A; Foti C; Marzullo A; Bonamonte D
Life (Basel); 2022 Jan; 12(2):. PubMed ID: 35207500
[TBL] [Abstract][Full Text] [Related]
2. Morphological and morphometric analysis of cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa: a retrospective study.
Filoni A; Cicco G; Lospalluti L; Maglietta A; Foti C; Annichiarico G; Resta L; Bonamonte D
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1707-1714. PubMed ID: 31692111
[TBL] [Abstract][Full Text] [Related]
3. Reprogramming and Differentiation of Cutaneous Squamous Cell Carcinoma Cells in Recessive Dystrophic Epidermolysis Bullosa.
Rami A; Łaczmański Ł; Jacków-Nowicka J; Jacków J
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33383666
[TBL] [Abstract][Full Text] [Related]
4. Unravelling drivers of cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.
Santucci C; Alexandru M; Chen X; Mellerio JE; Karagiannis SN; Jacków-Malinowska J
Hum Immunol; 2024 May; 85(3):110805. PubMed ID: 38703415
[TBL] [Abstract][Full Text] [Related]
5. Inherited epidermolysis bullosa and squamous cell carcinoma: a systematic review of 117 cases.
Montaudié H; Chiaverini C; Sbidian E; Charlesworth A; Lacour JP
Orphanet J Rare Dis; 2016 Aug; 11(1):117. PubMed ID: 27544590
[TBL] [Abstract][Full Text] [Related]
6. Metformin shows anti-neoplastic properties by inhibition of oxidative phosphorylation and glycolysis in epidermolysis bullosa-associated aggressive cutaneous squamous cell carcinoma.
Welponer T; Weber DD; Trattner L; Tockner B; Aminzadeh-Gohari S; Leb-Reichl V; Kaufmann A; Zauner R; Wimmer M; Wally V; Felder TK; Strunk D; Koller U; Bauer JW; Kofler B; Guttmann-Gruber C; Piñon Hofbauer J
J Eur Acad Dermatol Venereol; 2024 Jan; 38(1):112-123. PubMed ID: 37669776
[TBL] [Abstract][Full Text] [Related]
7. Variable Outcome of Immunotherapy in Advanced Multiple Cutaneous Squamous Cell Carcinomas in Two Patients with Recessive Dystrophic Epidermolysis Bullosa.
Trefzer L; Hess ME; Scholten L; Technau-Hafsi K; Meiss F; Boerries M; Has C; Rafei-Shamsabadi D
Acta Derm Venereol; 2023 Jun; 103():adv4870. PubMed ID: 37338146
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa.
Ng YZ; Pourreyron C; Salas-Alanis JC; Dayal JH; Cepeda-Valdes R; Yan W; Wright S; Chen M; Fine JD; Hogg FJ; McGrath JA; Murrell DF; Leigh IM; Lane EB; South AP
Cancer Res; 2012 Jul; 72(14):3522-34. PubMed ID: 22564523
[TBL] [Abstract][Full Text] [Related]
9. Successful use of immunotherapy to treat advanced cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.
Duong T; Wong D; Barrett A; Price H
BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33637494
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneous addiction to transforming growth factor-beta signalling in recessive dystrophic epidermolysis bullosa-associated cutaneous squamous cell carcinoma.
Dayal JHS; Mason SM; Salas-Alanis JC; McGrath JA; Taylor RG; Mellerio JE; Blyth K; South AP; Inman GJ
Br J Dermatol; 2021 Apr; 184(4):697-708. PubMed ID: 32726455
[TBL] [Abstract][Full Text] [Related]
11. Identification of tissue damage, extracellular matrix remodeling and bacterial challenge as common mechanisms associated with high-risk cutaneous squamous cell carcinomas.
Föll MC; Fahrner M; Gretzmeier C; Thoma K; Biniossek ML; Kiritsi D; Meiss F; Schilling O; Nyström A; Kern JS
Matrix Biol; 2018 Mar; 66():1-21. PubMed ID: 29158163
[TBL] [Abstract][Full Text] [Related]
12. Fibrosis as a Risk Factor for Cutaneous Squamous Cell Carcinoma in Recessive Dystrophic Epidermolysis Bullosa: A Systematic Review.
de Azevedo BLR; Roni GM; Torrelio RMF; da Gama-de-Souza LN
J Pediatr Genet; 2023 Jun; 12(2):97-104. PubMed ID: 37090823
[TBL] [Abstract][Full Text] [Related]
13. Injury-Driven Stiffening of the Dermis Expedites Skin Carcinoma Progression.
Mittapalli VR; Madl J; Löffek S; Kiritsi D; Kern JS; Römer W; Nyström A; Bruckner-Tuderman L
Cancer Res; 2016 Feb; 76(4):940-51. PubMed ID: 26676755
[TBL] [Abstract][Full Text] [Related]
14. Over-expression of stromal periostin correlates with poor prognosis of cutaneous squamous cell carcinomas.
Lincoln V; Chao L; Woodley DT; Murrell D; Kim M; O'Toole EA; Ly A; Cogan J; Mosallaei D; Wysong A; Chen M
Exp Dermatol; 2021 May; 30(5):698-704. PubMed ID: 33450077
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and natural history of cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa patients: 20 years' experience of a reference centre in Spain.
Castelo B; Viñal D; Maseda R; Ostios L; Sánchez D; García-Salvatierra B; Escámez MJ; Martínez-Santamaría L; Del Río M; Mora-Rillo M; Vilches Y; Beato MJ; López Gutiérrez JC; Romero N; Santos C; Miranda J; de Lucas R
Clin Transl Oncol; 2019 Nov; 21(11):1573-1577. PubMed ID: 30864020
[TBL] [Abstract][Full Text] [Related]
16. Update on the pathogenesis of squamous cell carcinoma development in recessive dystrophic epidermolysis bullosa.
Kim M; Murrell DF
Eur J Dermatol; 2015 Apr; 25 Suppl 1():30-2. PubMed ID: 26083672
[TBL] [Abstract][Full Text] [Related]
17. Basic fibroblast growth factor: a missing link between collagen VII, increased collagenase, and squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.
Arbiser JL; Fine JD; Murrell D; Paller A; Connors S; Keough K; Marsh E; Folkman J
Mol Med; 1998 Mar; 4(3):191-5. PubMed ID: 9562977
[TBL] [Abstract][Full Text] [Related]
18. Recessive dystrophic epidermolysis bullosa skin displays a chronic growth-activated immunophenotype. Implications for carcinogenesis.
Smoller BA; McNutt NS; Carter DM; Gottlieb AB; Hsu A; Krueger J
Arch Dermatol; 1990 Jan; 126(1):78-83. PubMed ID: 1688702
[TBL] [Abstract][Full Text] [Related]
19. Biomarker Discovery in Rare Malignancies: Development of a miRNA Signature for RDEB-cSCC.
Zauner R; Wimmer M; Atzmueller S; Proell J; Niklas N; Ablinger M; Reisenberger M; Lettner T; Illmer J; Dorfer S; Koller U; Guttmann-Gruber C; Hofbauer JP; Bauer JW; Wally V
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444397
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous squamous cell carcinoma developing from recessive dystrophic epidermolysis bullosa: a case report and an immunohistochemical study.
Tsukada A; Fujimura T; Furudate S; Kambayashi Y; Numata Y; Haga T; Hashimoto A; Aiba S
Case Rep Dermatol; 2012 Sep; 4(3):197-201. PubMed ID: 23271994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
